Drugs Made In America Acquisition Corp. - Units
Rank #1001376Drugs Made In America Acquisition Corp. - Units Asset pricing index
30-Day Price Trend (USD)
Asset Specs Sheet
Live financial data stream and supply cap specifications index for Drugs Made In America Acquisition Corp. - Units (DMAAU).
Frequently Asked Questions (FAQ)
Q: What is the current market valuation and pricing of Drugs Made In America Acquisition Corp. - Units (DMAAU)?
A: As of today, Drugs Made In America Acquisition Corp. - Units is priced at $10.71, supporting a 24-hour volume index of $75.
Q: How does the price of Drugs Made In America Acquisition Corp. - Units compare to its historical extremes?
A: Drugs Made In America Acquisition Corp. - Units's historical peak (ATH) was recorded at N/A. Currently, it trades at $10.71.
Q: Where is DMAAU data calculated and sourced from?
A: All ticker stats are evaluated and streamed via our centralized Supabase storage feeds, connected to public pricing feeds to provide dynamic market valuations.
Educational Guide: Understanding Drugs Made In America Acquisition Corp. - Units Metrics
1. Market Cap Definition
The market capitalization of Drugs Made In America Acquisition Corp. - Units is calculated by multiplying its total circulating supply (0 DMAAU) by the current market rate ($10.71). This metric measures the relative size of an asset within the global financial ecosystem.
2. Circulating vs. Total Supply
Circulating supply measures the units that are actively tradable in public markets. Total supply represents all units issued to date, minus any that have been removed from circulation. For Drugs Made In America Acquisition Corp. - Units, the total issued supply limit is unlimited/dynamic.
3. Trading Volume Dynamics
A 24-hour trading volume of $75.00 shows the aggregate liquidity and exchange activity of DMAAU over the last full daily cycle. Higher volume indicates stronger market depth and easier order execution.